glp 1 agonist lilly Eli to seek approval of new GLP-1 weight-loss drug this year lilly glp 1 agonist Lilly's

Study-related adverse events Adverse reactions reported in 5% of patients and occurring more frequently with Victoza compared with placebo included nausea (21.4% vs 4.4%), vomiting (12.1% vs 2.2%), diarrhea (7.1% vs 2.9%), constipation (5.7% vs 1.5%), increased lipase (15.0% vs 8.8%), GFR decreased (6.4% vs 5.1%), and headache (5.0% vs 2.9%)

Olive oil Olive oil has long been recognized for its cardiometabolic benefits and protective role in NAFLD

Distinguish between adjustment and genuine problems

A drug patch releases a chemical into your body that then is distributed systemically via the bloodstream

Lets talk about GLP-1

AIDs IN WEIGHT LOSS, HAVE MORE ENERGY